News - 17 May `16Quarterly research review: new findings may improve quality of life.

New

Our new Quarterly Review covers 59 papers on vitiligo published between October and December 2015. Among other significant findings, take note of that once-a-week treatment with targeted UVB seems to be as efficient as commonly used bi-weekly protocol for repigmentation of vitiligo lesions. Read highlights or download.

      FAQOther Questions

      • Who is prone to vitiligo?

        Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...

      • Is there a traditional medicine to treat vitiligo?

        Traditional medicines may be helpful in chronic, metabolic, and stress-related conditions early in the disease manifestation, before extensive tissue and organ damage has occurr...

      • Does halo nevi affect vitiligo development?

        Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...